CORCEPT THERAPEUTICS INC·4

Sep 11, 8:38 PM ET

Swisher Daniel N JR 4

4 · CORCEPT THERAPEUTICS INC · Filed Sep 11, 2025

Insider Transaction Report

Form 4
Period: 2025-09-10
Transactions
  • Sale

    Common Stock

    2025-09-10$72.45/sh2,200$159,3900 total
  • Exercise/Conversion

    Stock option (right to buy)

    2025-09-102,2003,300 total
    Exercise: $14.08Exp: 2028-08-20Common Stock (2,200 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-10$14.08/sh+2,200$30,9762,200 total
Footnotes (2)
  • [F1]The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
  • [F2]Fully exercisable.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4